Plerixafor Impurity 15 | CAS 110078-47-2 - Request Quote
Plerixafor Impurity 15
| SZ CAT No: | SZ-P070020 |
| CAS No | 110078-47-2 |
| Mol.F. | C70H90N8O12S6 |
| Mol.Wt. | 1427.9 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Plerixafor Impurity 15 is chemically 1,4-Bis((4,8,11-tritosyl-1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene. Plerixafor Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Plerixafor Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Plerixafor.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 110078-47-2
Purchase 110078-47-2
Order 110078-47-2
Enquire 110078-47-2
price of 110078-47-2
110078-47-2 Supplier
110078-47-2 Manufacturer
110078-47-2 Exporter
buy high quality Plerixafor Impurity 15
Purchase Plerixafor Impurity 15
Plerixafor Impurity 15 suppliers
Plerixafor Impurity 15 manufacturers
Plerixafor Impurity 15 price
Order Plerixafor Impurity 15
Enquire Plerixafor Impurity 15
Plerixafor Impurity 15 cost
Plerixafor Impurity 15 Supplier
Plerixafor Impurity 15 Distributor
Plerixafor Impurity 15 for Method Validation
Plerixafor Reference Standard
Plerixafor Impurity 15 for ANDA Filing
Plerixafor Impurity 15 for Forced Degradation Studies
Plerixafor Impurity 15 Identification Standards
Plerixafor Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


